• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

RFA targets head and neck tumors

Article

Radio-frequency ablation of unresectable hepatic and renal tumors has achieved considerable success, but the technique has not been widely tested in other organs. RFA may considerably reduce the size of advanced tumors in the mouth and throat and alleviate pain, according to a pioneering study by a New York City group.

Radio-frequency ablation of unresectable hepatic and renal tumors has achieved considerable success, but the technique has not been widely tested in other organs. RFA may considerably reduce the size of advanced tumors in the mouth and throat and alleviate pain, according to a pioneering study by a New York City group.

Researchers at Albert Einstein College of Medicine's Montefiore Medical Center treated seven tumors in six patients in a preliminary report published in the August issue of Head and Neck. Tumor size ranged from 2 to 15 cm, with masses located on the tongue, oropharynx, neck, and elsewhere. All patients reported significant pain relief. Given the tumors' locations, ultrasound wasn't nearly as useful as a laryngoscope for guiding treatment, but MR and CT identified tumors and guided planning for the procedures. Here, CT shows a peritonsillar mass. While the procedure has proved safe so far, collateral damage to surrounding tissue and cranial nerves remains a concern. Though RFA is for now a palliative measure, it could turn out to be a curative technique, the authors said.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.